| Symbol | LBRX |
|---|---|
| Name | LB PHARMACEUTICALS INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | United States |
| Telephone | 917-450-6581 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001691082 |
| Description |
New Form SCHEDULE 13G/A - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001193125-26-226892 <b>Size:</b> 13 KB
Read moreNew Form SCHEDULE 13G/A - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001831942-26-000020 <b>Size:</b> 15 KB
Read moreNew Form SCHEDULE 13G - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001727492-26-000009 <b>Size:</b> 9 KB
Read moreNew Form SCHEDULE 13G/A - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0000019617-26-000216 <b>Size:</b> 7 KB
Read more(10% Negative) LB PHARMACEUTICALS INC (LBRX) Reports Q2 2026 Financial Results
Read moreLB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
Read moreNew Form 424B3 - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001193125-26-219851 <b>Size:</b> 2 MB
Read moreNew Form DEFA14A - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001193125-26-173708 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - LB PHARMACEUTICALS INC <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001193125-26-173679 <b>Size:</b> 1 MB
Read moreLB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
Read more